BRIEF-Biosyent signs distribution agreement for new cardiovascular products
May 25 (Reuters) - Biosyent Inc:
* Biosyent signs exclusive distribution agreement for two new cardiovascular products
* Intends to submit dossier seeking marketing approval of products to Health Canada in 2016
* Forecasts that the new products will add approximately CAD $20 million to overall revenue of company when they reach "peak sales" Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.